What is PFND stock price today?

PFND (Pathfinder Cell Therapy Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PFND stock going up or down today?

PFND stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PFND stock now?

The decision to buy PFND depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PFND a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PFND based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PFND stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PFND is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PFND's P/E ratio?

P/E ratio data for PFND will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PFND's market cap?

PFND (Pathfinder Cell Therapy Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is PFND's price to book ratio?

Price-to-book ratio for PFND is available on our dashboard along with other valuation metrics.

Does PFND pay dividends?

PFND does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PFND's dividend yield?

PFND does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PFND stock a good long-term investment?

PFND's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PFND's revenue growth rate?

Revenue growth data for PFND is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PFND are available on our dashboard with complete income statement analysis.

What are the risks of investing in PFND?

Key risks for PFND include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PFND compare to its competitors?

Compare PFND to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PFND's performance and positioning.

What is PFND's stock price target for 2026?

Our AI model provides price targets for PFND based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PFND?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PFND. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PFND's next earnings report?

PFND reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PFND - Pathfinder Cell Therapy Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Pathfinder Cell Therapy Inc

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.

PFND Key Statistics

Market Cap

$0.07M

000

Employees

How PFND Compares to Peers

PFND is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PFND(This stock)	$66.72K	N/A	0%	0.0%	-
AMGNAmgen Inc	$191.53B	24.9	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.91B	20.9	-0%	0.1%	vs BIIB

Pathfinder Cell Therapy Inc Company Information

Headquarters: 12 Bow Street, Cambridge, MA, United States, 02138, undefined
Website: www.pathfindercelltherapy.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 21, 2026 at 9:37 AM EDT

Ready to invest in PFND?

Commission-free trading available. Affiliate links.

Upcoming Events for PFND

Dashboard

Enter a ticker to analyze